0.07Open0.07Pre Close0 Volume4 Open Interest4.00Strike Price0.00Turnover1292.61%IV388.60%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type0.2064Delta0.3023Gamma11.91Leverage Ratio-0.0438Theta0.0000Rho2.46Eff Leverage0.0002Vega
Sangamo Therapeutics Stock Discussion
Gene Editing Therapeutics Market Report 2024, Featuring Profiles of Key Players Allogene Therapeutics, CRISPR Therapeutics, Intellia Therapeutics, Sangamo Therapeutics and Vertex Pharmaceuticals - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Gene Editi
https://www.moomoo.com/t/news/post/43596799/BYnzVJBmba
Bought big Friday, looks like I made the right call. GLTA
No comment yet